IHF - iShares U.S. Healthcare Providers ETF
| Previous Close | 164.22 |
| Open | 164.37 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 163.64 - 164.56 |
| 52 Week Range | 135.46 - 172.85 |
| Volume | 9,742 |
| Avg. Volume | 19,895 |
| Net Assets | 471.26M |
| NAV | 157.09 |
| PE Ratio (TTM) | N/A |
| Yield | 0.23% |
| YTD Return | 0.75% |
| Beta (3y) | 0.66 |
| Expense Ratio (net) | 0.44% |
| Inception Date | 2006-05-01 |
- Motley Fool•last month
How to Invest in Healthcare Stocks the Easy Way
Here are several smart ways to invest in the companies that keep people healthy.
- ETF Trends•2 months ago
Cigna, Express Shares Deal is Not Enough for Healthcare ETFs
Cigna Group (NYSE: CI) agreed to acquire Express Scripts Holdings (NasdaqGS: ESRX), but healthcare sector-specific exchange traded funds remain relatively muted. For instance, the iShares U.S. Healthcare ...
- Zacks•4 months ago
Sector ETFs to Win on Strong November Job Data
These sector ETFs may win over the medium-term on decent job growth.
- InvestorPlace•5 months ago
Mixed Prognosis for Healthcare Stocks
If someone had told you at the beginning of the year that the Republican-controlled Congress was going to try and fail to repeal and replace the Affordable Care Act (ACA) multiple times during 2017, you probably wouldn’t have believed them. You might think that this uncertainty would have taken a bearish toll on healthcare stocks, but you’d be wrong in most cases. Many healthcare stocks are keeping pace with, or outperforming, the S&P 500.
- Zacks•9 months ago
ETFs to Win or Lose Post June Jobs Data
June jobs data came in better than expected and put these ETFs in focus.
- Zacks•10 months ago
Top-Ranked Health Care ETFs to Buy Now
After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.
- CNBC Videos•3 months ago
Health-care ETFs in focus on JP Morgan-Berkshire-Amazon d...
CNBC's Mike Santoli takes a look at which ETFs could be affected by the announcement that J.P. Morgan, Berkshire Hathaway and Amazon are teaming up to form a health-care company.
Yahoo Finance Video•8 months agoWhy a $475,000 drug price tag isn't expensive
Novartis got government approval for a new cancer therapy. The treatment will cost a staggering $475,000, and it will help children and young adults with a certain type of Leukemia. Yahoo Finance's Seana Smith, Nicole Smith and Rick Newman react to what Wall Street is saying about the drug.
Yahoo Finance Video•10 months agoWhy investors flipped 180 on health care stocks today: NYSE trader
Yahoo Finance's Alexis Christoforous is joined by Keith Bliss of Cuttone and Company from the floor of the New York Stock Exchange to discuss the proposed Senate bill that repeals and replaces Obamacare.
